Skip to main content
Log in

Neuronal responses mediated by activation of the non-NMDA receptors: Potentiation by nootropes

  • Published:
Neurophysiology Aims and scope

Abstract

Experiments on superfused slices of rat hippocampus showed that the nootropic drugs pyracetam, ethymizol, ambocarb, and nooglutil increase the amplitude of populational EPSP (pEPSP) of neurons of the dentate gyrus evoked by electrical stimulation of the perforant pathway (PP). Nootropes exert no effect on the process of presynaptic glutamate liberation from the PP axons, but increase the chemosensitivity of the postsynaptic AMPA/kainate receptors mediating EPSP generation in the dentate gyrus neurons. Inhibitors of protein kinase (A-buthamide) and guanylatecyclase (methylene blue) do not modify the effects of nootropes. The nootrope-induced potentiation of pEPSP does not develop against the background of the application of calmodulin inhibitor W-7. In the presence of protein kinase inhibitor C, polymixin B, nootropes reversibly depress pEPSP in the dentate gyrus neurons. Blocking of the NMDA receptor ionic channels by ketamine and of the voltage-dependent T-type calcium channels by Ni2+ does not significantly modify the effects of nootropic drugs. A blocker of Ca2+-ATPase of the Ca2+ stores sodium orthovanadate, potentiates the effects of nootropes. Dantrolene, which disrupts Ca2+ liberation from the non-mitochondrical depots, blocks the effects of nootropes and diminishes pEPSP depression evoked by nootropes in the presence of polymixin B. On the basis of presented data, it is supposed that nootropic drugs assist Ca2+ liberation from the neuronal depots and activate calmodulin-dependent protein kinase and protein kinase C. Protein kinases phosphorylate the intracellular domains of the AMPA/kainate receptors, and this process results in an increase in their sensitivity to excitatory amino acids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. I. Kovalev,Nootropic Drugs, Nizh.-Volzh. Knizhnoe Izdatel'stvo, Volgograd (1990).

    Google Scholar 

  2. M. Krug, M. Koch, E. Shoof, et al., “Methylglucamine orotate, a memory-improving drug, prolongs hippocampal long-term potentiation,”Eur. J. Pharmacol.,173, No. 2/3, 223–226 (1989).

    PubMed  Google Scholar 

  3. A. J. Silva, C. F. Stevens, S. Tonegava, et al., “Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice,”Science, No. 5067, 201–206 (1992).

  4. G. Tocco, A. J. Annala, M. Baudry, et al., “Learning of a hippocampal-dependent conditioning task changes the binding properties of AMPA receptors in rabbit hippocampus,”Behav. Biol.,58, No. 3, 222–231 (1992).

    Google Scholar 

  5. G. L. Collingridge, C. H. Davies, and K. G. Reyman, “Long-term potentiation in the rat hippocampal slicesin vitro is associated with a delayed increase in sensitivity ofCAI neurons to AMPA,”J. Physiol.,414, 23P (1989).

    Google Scholar 

  6. I. Ito, S. Tanabe, A. Kohda, et al., “Allosteric potentiation of quisqualate receptor by a nootropeic drug aniracetam,”J. Physiol.,424, 533–543 (1990).

    PubMed  Google Scholar 

  7. J. D. C. Lambert and R. S. G. Jones “A reevaluation of excitatory amino acid mediated synaptic transmission in rat dentate gyrus,”J. Neurophysiol.,64, No. 1, 119–132 (1990).

    PubMed  Google Scholar 

  8. J. Taube and P. A. Schwartzkrain, “Mechanisms of long-term potentiation: EPSP/spike dissociation intradendritic recording and glutamate sensitivity,”J. Neurosci.,8, No. 5, 1632–1644 (1988).

    PubMed  Google Scholar 

  9. M. Marchi, E. Besanaa, and M. Raiteri, “Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices,”Eur. J. Pharmacol.,185, No. 2/3, 247–249 (1990).

    PubMed  Google Scholar 

  10. R. D. Sheridan and P. Saggan, “Optical monitoring of presynaptic calcium changes in fura-2 loaded hippocampal slice,”Pflügers. Arch.,413, Suppl., No. 1, 87 (1990).

    Google Scholar 

  11. J. A. Kauer, R. C. Malenka, and R. A. Nicoll, “NMDA application potentiates synaptic transmission in the hippocampus,”Nature,334, No. 6197, 250–252 (1988).

    PubMed  Google Scholar 

  12. E. McGlademculoh, H. Yamamoto, S. E. Tan, et al., “Phosphorylation and regulation of glutamate receptors by calcium-calmodulin-dependent protein kinase II,”Nature,362, No. 6421, 640–642 (1993).

    PubMed  Google Scholar 

  13. D. Madison and R. Nicoll, “Norepinephrine decreases synaptic inhibition in the rat hippocampus,”Brain Res.,442, No. 1, 131–138 (1988).

    PubMed  Google Scholar 

  14. S. R. Glaum and R. J. Miller, “Activation of metabotropic glutamate receptors produced reciprocal regulation of iontotropic glutamate and GABA responses in the nucleus of the tractus solitarius,”J. Neurosci.,13, No. 4, 1636–1641 (1993).

    PubMed  Google Scholar 

  15. A. Ambrosini and J. Meldolesi, “Muscarinic and quisqualate receptor induced phosphoinositide hydrolysis in primary cultures striatal and hippocampal neurons. Evidence for differential mechanism of activation,”J. Neurochem.,53, No. 3, 825–833 (1989).

    PubMed  Google Scholar 

  16. D. D. Schoep, “Protein kinase C-mediated inhibition of excitatory amino acid stimulated phosphoinositide hydrolysis in the neonatal rat hippocampus,”Neurochem. Int.,15, No. 2, 131–136 (1989).

    Google Scholar 

  17. G. G. S. Collins and W. J. Richards, “Pharmacological evidence that protein kinase C modulates monosynaptic excitations in the olphactory cortex,”Naunyn-Schmiedeberg's Arch. Pharmacol.,341, No. 1/2, 114–122 (1990).

    Google Scholar 

  18. M. Sakurai, “Effect of intracellular injection of EGTA on synaptic plasticity in the cerebellar cortex,”Neuroscience,5, Suppl., No. 7, 77 (1988).

    Google Scholar 

  19. G. Pepe and G. Spignoli, “Nootropic drugs and brain cholinergic mechanisms,”Prog. Neuro-Psychopharmacol. Biol. Psychiat.,13, Suppl., 77–88 (1989).

    Google Scholar 

  20. I. I. Abramets, I. I. Komissarov, and I. V. Samoilovich, “Multiple mechanisms underlying nootropic drug-induced enhancement of neuronal responses mediated by activation of glutamate NMDA-type receptors,”Neirofiziologiya/Neurophysiology,1, No. 3, 179–184 (1993).

    Google Scholar 

  21. R. Valinow, D. V. Madison, and R. W. Tsien, “Persistent protein kinase activity underlying long-term potentiation,”Nature,335, No. 6193, 820–824 (1988).

    PubMed  Google Scholar 

  22. E. Klann, C. E. Chen, and J. D. Sweatt, “Persistent protein kinase activation in the maintenance phase of long-term potentiation,”J. Biol. Chem.,226, No. 36, 24253–24256 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Neirofiziologiya/Neurophysiology, Vol. 26, No. 5, pp. 365–372, September–October, 1994.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abramets, I.I., Andreev, P.V., Komissarov, I.V. et al. Neuronal responses mediated by activation of the non-NMDA receptors: Potentiation by nootropes. Neurophysiology 26, 301–306 (1994). https://doi.org/10.1007/BF01058509

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01058509

Keywords

Navigation